Disorders of type I are suspect diseases in the field of genetic metabolism, clinical manifestations are complex and often involve multi-systematic stress. Early identification and standardization of clinical treatments are essential for improving prognosis. Diagnosis of this disease needs to be combined with clinical manifestations, imaging inspections, laboratory tests and pathological biopsies.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic diseases have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of type I osteoporosis. The platform serves a team of domestically and internationally authoritative experts in the field of genetic metabolism coupled with China's international medical service system, providing patients with the following services: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.